162 related articles for article (PubMed ID: 4299677)
41. Early detection of persistent trophoblastic tumour by serum human chorionic gonadotrophin monitoring after molar pregnancy.
Ngan HY; Wong LC
Chin Med J (Engl); 1999 Mar; 112(3):260-3. PubMed ID: 11593563
[TBL] [Abstract][Full Text] [Related]
42. Identification of patients with persistent trophoblastic disease by means of a normal human chorionic gonadotropin regression curve.
Yedema KA; Verheijen RH; Kenemans P; Schijf CP; Borm GF; Segers MF; Thomas CM
Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):787-92. PubMed ID: 7681253
[TBL] [Abstract][Full Text] [Related]
43. [The hormonology of pregnancy].
Lambotte R
Rev Med Liege; 1980 Sep; 35(17):575-7. PubMed ID: 7455434
[No Abstract] [Full Text] [Related]
44. Trophoblastic disease monitoring: Evaluation of pregnancy-specific beta 1-glycoprotein.
O'Brien TJ; Engvall E; Schlaerth JB; Morrow CP
Am J Obstet Gynecol; 1980 Oct; 138(3):313-20. PubMed ID: 6251725
[TBL] [Abstract][Full Text] [Related]
45. Comparison of human chorionic gonadotrophin concentrations in the sera of patients with normal and abnormal pregnancy measured by radio-immunoassay and immunoradiometric assay.
Norman RJ; Buck RH; Joubert SM
S Afr Med J; 1989 Apr; 75(7):318-9. PubMed ID: 2538933
[TBL] [Abstract][Full Text] [Related]
46. Serum human chorionic somatomammotropin as an aid in the diagnosis of gestational trophoblastic disease.
Ajabor LN
Niger Med J; 1973 Jan; 3(1):32-4. PubMed ID: 4375913
[No Abstract] [Full Text] [Related]
47. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
Shaarawy M; el-Shobokshy AS; el-Noury AI
Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
[TBL] [Abstract][Full Text] [Related]
48. Radioimmunoassays.
Schlaff S
Clin Obstet Gynecol; 1979 Jun; 22(2):455-61. PubMed ID: 466885
[No Abstract] [Full Text] [Related]
49. [Choriocarcinoma in a male patient with circulating thyrotropic activity and adrenocortical hyperfunction].
Orgiazzi J; Rousset B; Cosentino C; Saez J; Tourniaire J
Ann Endocrinol (Paris); 1972; 33(3):272-3. PubMed ID: 4346619
[No Abstract] [Full Text] [Related]
50. Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole.
Bagshawe KD; Lawler SD; Paradinas FJ; Dent J; Brown P; Boxer GM
Lancet; 1990 May; 335(8697):1074-6. PubMed ID: 1970378
[TBL] [Abstract][Full Text] [Related]
51. Peptide hormones in assessing fetal status.
Spellacy WN
Clin Perinatol; 1974 Mar; 1(1):65-72. PubMed ID: 4470050
[No Abstract] [Full Text] [Related]
52. [The serum concentration of specific beta 1-glycoprotein in trophoblastic disease].
Radikov N
Akush Ginekol (Sofiia); 1989; 28(2):15-9. PubMed ID: 2548413
[TBL] [Abstract][Full Text] [Related]
53. Circulating concentrations of specific placental proteins (human chorionic gonadotropin, pregnancy-specific beta-1 glycoprotein, and placental protein 5) in untreated gestational trophoblastic tumors.
Lee JN; Salem HT; Al-Ani AT; Chard T; Huang SC; Ouyang PC; Wei PY; Seppälä M
Am J Obstet Gynecol; 1981 Mar; 139(6):702-4. PubMed ID: 6971058
[TBL] [Abstract][Full Text] [Related]
54. The concentration of HCG in the plasma and spinal fluid of patients with trophoblastic tumours in the central nervous system.
Rushworth AG; Orr AH; Bagshawe KD
Br J Cancer; 1968 Jun; 22(2):253-7. PubMed ID: 4298235
[No Abstract] [Full Text] [Related]
55. Serum testosterone and dihydrotestosterone in patients with trophoblastic disease.
Dawood MY; Saxena BB
Obstet Gynecol; 1976 Jun; 47(6):684-8. PubMed ID: 180465
[TBL] [Abstract][Full Text] [Related]
56. [Behavior of placental lactogen in vesicular mole].
Tolino A; Mastrantonio P; Cardone A; Tinelli FG
Arch Ostet Ginecol; 1980; 85(1-2):39-44. PubMed ID: 7195703
[No Abstract] [Full Text] [Related]
57. A method of solid phase radioimmunoassay utilizing polypropylene discs.
Crosignani PG; Nakamura RM; Hovland DN; Mishell DR
J Clin Endocrinol Metab; 1970 Feb; 30(2):153-60. PubMed ID: 5409526
[No Abstract] [Full Text] [Related]
58. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
[TBL] [Abstract][Full Text] [Related]
59. [Fluctuations of plasma progesterone, 17alpha-OH-progesterone and estrogens in trophoblastic diseases (author's transl)].
Miyamoto T
Nihon Naibunpi Gakkai Zasshi; 1977 Mar; 53(3):203-20. PubMed ID: 199477
[No Abstract] [Full Text] [Related]
60. Serum progesterone monitoring in post-molar surveillance.
Vasilev SA; Schlaerth JB; Ahn C; Sauer MV
Gynecol Oncol; 1994 Sep; 54(3):288-91. PubMed ID: 7522199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
